Abstract
Background
Population aging is an important problem worldwide, with activity and quality of daily living commonly reduced in elderly people. leading to increased hospitalization and mortality rates, and substantial individual and social burdens.
Objective
This study was designed to investigate the associations of serum homocysteine levels with activity and quality of daily living in Chinese centenarians for the first time.
Participants
The China Hainan Centenarian Cohort Study was performed in 18 cities and counties of Hainan Province.
Main measures
Home interview, physical examination and blood analysis were performed in 787 centenarians following standard procedures.
Key results
The median age was 102 years, ranging between 100 and 115 years. There were 634 females (80.6%) and 153 males (19.4%) in all. The median level of serum homocysteine was 23.80 (18.80-29.90) umol/L, whereas median values of Barthel Index and EuroQol 5 Dimensions were 85(60-95) and 0.661(0.558-0.766), respectively. The centenarians with serum homocysteine levels ≥23.8μmol/L were more likely to had lower values of Barthel Index and EuroQol 5 Dimensions than those with serum homocysteine levels <23.8μmol/L (P<0.05 for all). In multivariate linear regression analyses, serum homocysteine levels were significantly associated with Barthel Index and EuroQol 5 Dimensions (P<0.05 for all).
Conclusions
Serum homocysteine levels had important associations with activity and quality of daily living in Chinese centenarians. Future research should focus on the value of intervening in serum homocysteine levels by supplying folic acid (vitamin B9) and vitamin B12 on improving activity and quality of daily living in elderly people.
Similar content being viewed by others
References
de Koning EJ, van der Zwaluw NL, van Wijngaarden JP, Sohl E, Brouwer-Brolsma EM, van Marwijk HW, Enneman AW, Swart KM, van Dijk SC, Ham AC, van der Velde N, Uitterlinden AG, Penninx BW, Elders PJ, Lips P, Dhonukshe-Rutten RA, van Schoor NM, de Groot LC. Effects of Two-Year Vitamin B12 and Folic Acid Supplemeon Depressive Symptoms and Quality of Life in Older Adults with Elevated Homocysteine Concentrations: Additional Results from the B-PROOF Study, an RCT. Nutrients. 2016;8(11).
Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002;325(7374), 1202.
Bates CJ, Mansoor MA, Pentieva KD, Hamer M, Mishra GD. Biochemical risk indices, including plasma homocysteine, that prospectively predict mortality in older British people: the National Diet and Nutrition Survey of People Aged 65 Years and Over. Br J Nutr. 2010;104(6), 893–9.
Andreeva VA, Latarche C, Hercberg S, Briançon S, Galan P, Kesse-Guyot E. B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial. PLoS One. 2014;9(1), e84844.
Hvas AM, Juul S, Nexø E, Ellegaard J. Vitamin B-12 treatment has limited effect on health-related quality of life among individuals with elevated plasma methylmalonic acid: a randomized placebo-controlled study. J Intern Med. 2003;253(2), 146–52.
Ng TP, Aung KC, Feng L, Scherer SC, Yap KB. Homocysteine, folate, vitamin B-12, and physical function in older adults: Cross-sectional findings from the Singapore Longitudinal Ageing Study. Am J Clin Nutr. 2012;96(6), 1362–8.
Wong YY, Almeida OP, McCaul KA, Yeap BB, Hankey GJ, van Bockxmeer FM, Flicker L. Elevated homocysteine is associated with poorer self-perceived physical health in older men: the Health in Men Study. Maturitas. 2012;73(2), 158–63.
Gariballa, S. Extending the homocysteine-induced neurotransmitter deficiency and depression of mood hypothesis to quality of life in older patients. Int J Geriatr Psychiatry. 2013;28(8), 878–9.
He Y, Zhao Y, Yao Y, Yang S, Li J, Liu M, Chen X, Wang J, Zhu Q, Li X, Zhang F, Luan F. Cohort Profile: The China Hainan Centenarian Cohort Study (CHCCS). Int J Epidemiol. 2018;doi: 10.1093/ije/dyy017.
Sainsbury A, Seebass G, Bansal A, Young JB. Reliability of the Barthel Index when used with older people. Age and ageing. 2005;34, 228–232.
Quinn TJ, Langhorne P, Stott DJ. Barthel index for stroke trials: development, properties, and application. Stroke. 2011;42, 1146–1151.
Liu GG, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value Health. 2014;17(5), 597–604.
Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ. 1998;316(7133), 736–41.
Wu XQ, Ding J, Ge AY, Wang X, Fan W. Acute phase homocysteine related to severity and outcome of atherothrombotic stroke - reply. Eur J Intern Med. 2014;25(1), e15.
Lee M, Hong KS, Chang SC, Saver JL. Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke. 2010;41(6), 1205–12.
Markišic M, Pavlovic AM, Pavlovic DM. The Impact of Homocysteine, Vitamin B12, and Vitamin D Levels on Functional Outcome after First-Ever Ischaemic Stroke. Biomed Res Int. 2017, 5489057.
VITATOPS Trial Study Group. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol. 2010;9(9), 855–65.
He Y, Li Y, Chen Y, Feng L, Nie Z. Homocysteine level and risk of different stroke types: a meta-analysis of prospective observational studies. Nutr Metab Cardiovasc Dis. 2014;24(11), 1158–65.
Kelemen LE, Anand SS, Hegele RA, Stampfer MJ, Rosner B, Willett WC, Montague PA, Lonn E, Vuksan V, Teo KK, Devanesen S, Yusuf S. Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians. Atherosclerosis. 2004;176(2), 361–70.
Wouters-Wesseling W, Wouters AE, Kleijer CN, Bindels JG, de Groot CP, van Staveren WA. Study of the effect of a liquid nutrition supplement on the nutritional status of psycho-geriatric nursing home patients. Eur J Clin Nutr. 2002;56(3), 245–51.
Homocysteine Lowering Trialists’ Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr. 2005;82(4), 806–12.
Pieters B, Staals J, Knottnerus I, Rouhl R, Menheere P, Kessels A, Lodder J. Periventricular white matter lucencies relate to low vitamin B12 levels in patients with small vessel stroke. Stroke. 2009;40(5), 1623–6.
Saposnik G. The role of vitamin B in stroke prevention: a journey from observational studies to clinical trials and critique of the VITAmins TO Prevent Stroke (VITATOPS). Stroke. 2011;42(3), 838–42.
Author information
Authors and Affiliations
Corresponding author
Additional information
Joint first authors.
Rights and permissions
About this article
Cite this article
Fu, S., Yao, Y., Lv, F. et al. Serum Homocysteine Levels Had Important Associations with Activity and Quality of Daily Living in Chinese Centenarians. J Nutr Health Aging 23, 479–482 (2019). https://doi.org/10.1007/s12603-019-1189-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-019-1189-7